A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

By Brendan Pierson and Dietrich Knauth (Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four ...

Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...

By Brendan Pierson and Dietrich Knauth (Reuters) -A Washington state jury on Tuesday ordered Bayer to pay $100 million to ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...